The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Valeant Pharmaceuticals International Inc

TSX: VRX
Delayed quote

$26.05

Today's change-0.24 -0.91%
Updated June 30 4:00 PM EDT. Delayed by at least 15 minutes.
 

Valeant Pharmaceuticals International Inc

TSX: VRX
Delayed quote

$26.05

Today's change-0.24 -0.91%
Updated June 30 4:00 PM EDT. Delayed by at least 15 minutes.

Valeant Pharmaceuticals International Inc down $0.24

Valeant Pharmaceuticals International Inc closed lower Thursday, dropping $0.24 or 0.91% to $26.05. Over the last five days, shares have lost 8.08% and are down 81.47% for the last year to date. This security has underperformed the S&P TSX by 87.24% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward3.27×
  • Forward PEG0.16×
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$2.78
Updated June 30 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.20%Sector:HealthcareIndustry:Pharmaceuticals - Diversified

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue2,3722,7362,7872,732
Total other revenue--------
Total revenue2,3722,7362,7872,732
Gross profit1,7422,0602,1392,047
Total cost of revenue630677648685
Total operating expense2,3052,5422,3392,391
Selling / general / administrative813743698686
Research & development1039610281
Depreciation / amortization695789679585
Interest expense (income), net operating--------
Unusual expense (income)42195182177
Other operating expenses, total234330177
Operating income66195448342
Interest income (expense), net non-operating-427-433-420-413
Gain (loss) on sale of assets--------
Other--------
Income before tax-366-240-6-65
Income after tax-373-36252-52
Income tax, total7122-57-13
Net income-374-36250-53
Total adjustments to net income--------
Net income before extra. items-374-36250-53
Minority interest-11-2-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-374-36250-53
Inc. avail. to common incl. extra. items-374-36250-53
Diluted net income-374-36250-53
Dilution adjustment--------
Diluted weighted average shares345348351344
Diluted EPS excluding extraordinary itemsvalue per share-1.08-1.040.14-0.15
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-1.00-0.540.570.19